CONFERENCE REPORTS
XIII International HIV Resistance Workshop, 8-12 June
2004, Tenerife, Canary Islands
- Risk of NNRTI-resistance during STI: implications for SMART and other STI studies
- Persistent nevirapine resistance following mother to child transmission interventions
- Tipranavir resistance and viral response: L90M did not reduce response, recommendation to use with T-20
- Resistance in the UK: new approach to epidemiological studies
- Low AZT activity against HIV-2 infection
- No evidence for cross resistance between nevirapine and d4T
- Experimental compounds to target viral expression in latent cells
- Case of MDR reinfection with MDR virus
CONFERENCE REPORT
Keystone HIV Pathogenesis and Vaccine Development Conference, 12-18 April 2004, British Columbia, Canada